// App-Quantinova.ai

646 : Feasibility of assessing circulating tumor cells in patient-derived xenograft tumor models

Researchers

Presenter

  • Somdutta Roy

Principal Investigators

  • Kevin Martinez

  • Arturo Ramirez

  • Daniel Campton

  • Joshua Nordberg

  • Eric Kaldjian

  • Scott J. Dylla

  • Holger Karsunky

Medical Centers

  • Stemcentrx, Inc., South San Francisco, CA

  • RareCyte Inc., Dexter Ave N, Seattle, WA.

Locations

  • United States

Companies

  • RareCyte, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Cluster of differentiation 45

  • Epithelial Cell Adhesion Molecule

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved